Top 13 alternative sites to myrbetriqhcp.com

  1. toviazhcp.com
    toviazhcp.com
  2. Homepage | TOVIAZ® (fesoterodine fumarate) | Safety Info
    See risks & benefits for TOVIAZ®, an Rx treatment option for overactive bladder (OAB) patients with symptoms of urge urinary incontinence, urgency, and frequency.

  3. nourianzhcp.com
    nourianzhcp.com
  4. NOURIANZ™ (istradefylline) | Official Healthcare Professional Website
    NOURIANZ is an FDA-approved option. Learn about trial data, Important Safety Information, dosing, the patient access program & more.

  5. ampyra-hcp.com
    ampyra-hcp.com
  6. AMPYRA® (dalfampridine) | For Healthcare Professionals
    Learn more about AMPYRA. See clinical studies, patient videos and available financial assistance options. See Important Safety Information (including seizures) and Prescribing Information.

  7. gloperba.com
    gloperba.com
  8. GLOPERBA® (colchicine) | Official Healthcare Professional Website
    GLOPERBA is FDA-approved for the prophylaxis of gout flares in adults. Learn more about efficacy, safety, and dosing of the first and only liquid **** colchicine.

  9. zarxio.com
    zarxio.com
  10. ZARXIO® (filgrastim-sndz) | Patient Website
    Learn Why ZARXIO May Be a Treatment Option. ZARXIO Is An FDA-Approved Biosimilar. Safety Syringe. Information For Patients. Co-Pay Program. Patient Site. Patient Support Programs.

  11. firdapsehcp.com
    firdapsehcp.com
  12. FIRDAPSE® (amifampridine) | Healthcare Professional Site
    FIRDAPSE® (amifampridine)—the only FDA-approved, evidence-based treatment for adult patients with Lambert-Eaton myasthenic syndrome (LEMS). Please visit the website for Important Safety Information and Prescribing Information.

  13. rubracahcp.com
    rubracahcp.com
  14. Rubraca® (rucaparib) | Information for Healthcare Professionals
    Learn about Rubraca® (rucaparib), a PARP inhibitor approved to treat and benefit patients in 3 indications across 2 tumor types. Please see Indications and Important Safety Information.

  15. caplytahcp.com
    caplytahcp.com
  16. CAPLYTA® (lumateperone) | Healthcare Professionals
    Learn about CAPLYTA, indicated for the treatment of schizophrenia in adults. See efficacy, safety, dosing, pharmacology and savings information. Please see full Prescribing Information, including Boxed Warning.

  17. serostim.com
    serostim.com
  18. Serostim® (somatropin) for injection Official Patient Site
    Learn about treatment with FDA-approved Serostim®. Helpful resources include information on the condition, guide to taking Serostim, and other patient support.

  19. hcp.botoxcosmetic.com
    hcp.botoxcosmetic.com
  20. Welcome to BOTOXCosmetic.com for healthcare professionals! ǀ BOTOX® Cosmetic
    Learn about BOTOX® Cosmetic (onabotulinumtoxinA) for your practice. FDA approved to temporarily improve the appearance of moderate to severe forehead lines, lateral canthal lines, and glabellar lines in adults. See full Safety and Prescribing Information, including Boxed Warning and Medication Guide.

  21. supportincontinence.org
    supportincontinence.org
  22. Home - Support in Continence
    Welcome to Support in Continence Your search ends here! Keep reading for honest, straightforward and reliable advice about urinary (bladder) and faecal (bowel) incontinence. Start now Learn more To help us direct you to the most relevant information, please answer the three following questions: Question 1 of 3 What is your main reason for visiting […]

  23. otezlapro.com
    otezlapro.com
  24. Official Home Page of the Otezla® (apremilast) Healthcare Professional Site | Amgen Inc.
    Learn about Otezla® (apremilast), a treatment for adults with moderate to severe plaque psoriasis, active psoriatic arthritis, or **** ulcers associated with Behçet's disease. Review the mechanism of action (MOA), the clinical trial program, efficacy data, and safety information. Access educational materials for your patients and information about prescribing and starting patients on Otezla. Please see full Important Safety Information.

  25. praluenthcp.com
    praluenthcp.com
  26. Medication to Reduce Cardiovascular Risk | PRALUENT® (alirocumab) Injection
    Learn about PRALUENT, a PCSK9 inhibitor, that is approved to help reduce the risk of certain CV events in adults with established cardiovascular disease. Get access to ODYSSEY OUTCOMES trial data and read Important Safety Information on website.